Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activation (Q33499619)

From Wikidata
Jump to navigation Jump to search
scientific article published on 2 September 2009
edit
Language Label Description Also known as
English
Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activation
scientific article published on 2 September 2009

    Statements

    Thrombospondin-2 therapy ameliorates experimental glomerulonephritis via inhibition of cell proliferation, inflammation, and TGF-beta activation (English)
    0 references
    2 September 2009
    F1299-309

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit